Logo image of QIA.DE

QIAGEN N.V. (QIA.DE) Stock Fundamental Analysis

Europe - FRA:QIA - NL0015002CX3 - Common Stock

38.905 EUR
+0.45 (+1.16%)
Last: 9/18/2025, 5:36:15 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to QIA. QIA was compared to 19 industry peers in the Life Sciences Tools & Services industry. Both the health and profitability get an excellent rating, making QIA a very profitable company, without any liquidiy or solvency issues. QIA is not valued too expensively and it also shows a decent growth rate. These ratings would make QIA suitable for quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year QIA was profitable.
QIA had a positive operating cash flow in the past year.
Each year in the past 5 years QIA has been profitable.
In the past 5 years QIA always reported a positive cash flow from operatings.
QIA.DE Yearly Net Income VS EBIT VS OCF VS FCFQIA.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

QIA has a better Return On Assets (6.41%) than 78.95% of its industry peers.
QIA's Return On Equity of 10.65% is fine compared to the rest of the industry. QIA outperforms 78.95% of its industry peers.
QIA has a better Return On Invested Capital (8.66%) than 73.68% of its industry peers.
The Average Return On Invested Capital over the past 3 years for QIA is in line with the industry average of 7.19%.
The last Return On Invested Capital (8.66%) for QIA is above the 3 year average (7.25%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.41%
ROE 10.65%
ROIC 8.66%
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
QIA.DE Yearly ROA, ROE, ROICQIA.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

QIA has a Profit Margin of 18.30%. This is amongst the best in the industry. QIA outperforms 94.74% of its industry peers.
In the last couple of years the Profit Margin of QIA has declined.
QIA has a Operating Margin of 26.86%. This is amongst the best in the industry. QIA outperforms 100.00% of its industry peers.
QIA's Operating Margin has improved in the last couple of years.
The Gross Margin of QIA (64.18%) is better than 94.74% of its industry peers.
QIA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 26.86%
PM (TTM) 18.3%
GM 64.18%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
QIA.DE Yearly Profit, Operating, Gross MarginsQIA.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), QIA is creating some value.
QIA has less shares outstanding than it did 1 year ago.
The number of shares outstanding for QIA has been reduced compared to 5 years ago.
QIA has a better debt/assets ratio than last year.
QIA.DE Yearly Shares OutstandingQIA.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
QIA.DE Yearly Total Debt VS Total AssetsQIA.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

QIA has an Altman-Z score of 3.96. This indicates that QIA is financially healthy and has little risk of bankruptcy at the moment.
QIA has a Altman-Z score of 3.96. This is amongst the best in the industry. QIA outperforms 89.47% of its industry peers.
The Debt to FCF ratio of QIA is 2.91, which is a good value as it means it would take QIA, 2.91 years of fcf income to pay off all of its debts.
QIA has a better Debt to FCF ratio (2.91) than 84.21% of its industry peers.
QIA has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of QIA (0.25) is better than 89.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 2.91
Altman-Z 3.96
ROIC/WACC1.14
WACC7.58%
QIA.DE Yearly LT Debt VS Equity VS FCFQIA.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

QIA has a Current Ratio of 1.61. This is a normal value and indicates that QIA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.61, QIA is in the better half of the industry, outperforming 63.16% of the companies in the same industry.
A Quick Ratio of 1.35 indicates that QIA should not have too much problems paying its short term obligations.
QIA has a Quick ratio of 1.35. This is in the better half of the industry: QIA outperforms 73.68% of its industry peers.
Industry RankSector Rank
Current Ratio 1.61
Quick Ratio 1.35
QIA.DE Yearly Current Assets VS Current LiabilitesQIA.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 12.20% over the past year.
QIA shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.40% yearly.
QIA shows a small growth in Revenue. In the last year, the Revenue has grown by 5.15%.
Measured over the past years, QIA shows a small growth in Revenue. The Revenue has been growing by 5.32% on average per year.
EPS 1Y (TTM)12.2%
EPS 3Y-6.66%
EPS 5Y8.4%
EPS Q2Q%6.06%
Revenue 1Y (TTM)5.15%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%7.49%

3.2 Future

The Earnings Per Share is expected to grow by 8.02% on average over the next years. This is quite good.
QIA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.38% yearly.
EPS Next Y7.88%
EPS Next 2Y8.09%
EPS Next 3Y8.68%
EPS Next 5Y8.02%
Revenue Next Year5.25%
Revenue Next 2Y5.47%
Revenue Next 3Y5.89%
Revenue Next 5Y7.38%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
QIA.DE Yearly Revenue VS EstimatesQIA.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
QIA.DE Yearly EPS VS EstimatesQIA.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 19.65, QIA is valued on the expensive side.
QIA's Price/Earnings ratio is a bit cheaper when compared to the industry. QIA is cheaper than 78.95% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.41, QIA is valued a bit cheaper.
A Price/Forward Earnings ratio of 17.74 indicates a rather expensive valuation of QIA.
Compared to the rest of the industry, the Price/Forward Earnings ratio of QIA indicates a somewhat cheap valuation: QIA is cheaper than 78.95% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.88. QIA is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 19.65
Fwd PE 17.74
QIA.DE Price Earnings VS Forward Price EarningsQIA.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of QIA indicates a somewhat cheap valuation: QIA is cheaper than 68.42% of the companies listed in the same industry.
73.68% of the companies in the same industry are more expensive than QIA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 20.13
EV/EBITDA 13.76
QIA.DE Per share dataQIA.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of QIA may justify a higher PE ratio.
PEG (NY)2.49
PEG (5Y)2.34
EPS Next 2Y8.09%
EPS Next 3Y8.68%

2

5. Dividend

5.1 Amount

QIA has a yearly dividend return of 0.54%, which is pretty low.
Compared to an average industry Dividend Yield of 0.71, QIA pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, QIA's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.54%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y8.09%
EPS Next 3Y8.68%
QIA.DE Yearly Income VS Free CF VS DividendQIA.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

QIAGEN N.V.

FRA:QIA (9/18/2025, 5:36:15 PM)

38.905

+0.45 (+1.16%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-07 2025-11-07/amc
Inst Owners87.24%
Inst Owner ChangeN/A
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap8.44B
Analysts75
Price Target44.59 (14.61%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.54%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.7%
Min EPS beat(2)-2.4%
Max EPS beat(2)7.8%
EPS beat(4)2
Avg EPS beat(4)1.23%
Min EPS beat(4)-3.85%
Max EPS beat(4)7.8%
EPS beat(8)5
Avg EPS beat(8)1.51%
EPS beat(12)8
Avg EPS beat(12)3.69%
EPS beat(16)12
Avg EPS beat(16)5.44%
Revenue beat(2)1
Avg Revenue beat(2)0.66%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)1.43%
Revenue beat(4)1
Avg Revenue beat(4)-0.16%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)1.43%
Revenue beat(8)1
Avg Revenue beat(8)-0.61%
Revenue beat(12)3
Avg Revenue beat(12)-0.41%
Revenue beat(16)7
Avg Revenue beat(16)0.85%
PT rev (1m)0.81%
PT rev (3m)0.14%
EPS NQ rev (1m)0.43%
EPS NQ rev (3m)0.96%
EPS NY rev (1m)0.08%
EPS NY rev (3m)0.53%
Revenue NQ rev (1m)0.17%
Revenue NQ rev (3m)2%
Revenue NY rev (1m)0.9%
Revenue NY rev (3m)1.09%
Valuation
Industry RankSector Rank
PE 19.65
Fwd PE 17.74
P/S 4.89
P/FCF 20.13
P/OCF 14.79
P/B 2.85
P/tB 15.62
EV/EBITDA 13.76
EPS(TTM)1.98
EY5.09%
EPS(NY)2.19
Fwd EY5.64%
FCF(TTM)1.93
FCFY4.97%
OCF(TTM)2.63
OCFY6.76%
SpS7.95
BVpS13.66
TBVpS2.49
PEG (NY)2.49
PEG (5Y)2.34
Profitability
Industry RankSector Rank
ROA 6.41%
ROE 10.65%
ROCE 11.67%
ROIC 8.66%
ROICexc 10.87%
ROICexgc 46.44%
OM 26.86%
PM (TTM) 18.3%
GM 64.18%
FCFM 24.31%
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
ROICexc(3y)9.42%
ROICexc(5y)10.13%
ROICexgc(3y)34.6%
ROICexgc(5y)42.77%
ROCE(3y)9.77%
ROCE(5y)10.73%
ROICexcg growth 3Y-31.24%
ROICexcg growth 5Y-2.41%
ROICexc growth 3Y-13.09%
ROICexc growth 5Y6.48%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
F-Score8
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 2.91
Debt/EBITDA 1.2
Cap/Depr 94.78%
Cap/Sales 8.78%
Interest Coverage 250
Cash Conversion 91.61%
Profit Quality 132.83%
Current Ratio 1.61
Quick Ratio 1.35
Altman-Z 3.96
F-Score8
WACC7.58%
ROIC/WACC1.14
Cap/Depr(3y)78.4%
Cap/Depr(5y)95.94%
Cap/Sales(3y)7.97%
Cap/Sales(5y)9.87%
Profit Quality(3y)273.85%
Profit Quality(5y)189.74%
High Growth Momentum
Growth
EPS 1Y (TTM)12.2%
EPS 3Y-6.66%
EPS 5Y8.4%
EPS Q2Q%6.06%
EPS Next Y7.88%
EPS Next 2Y8.09%
EPS Next 3Y8.68%
EPS Next 5Y8.02%
Revenue 1Y (TTM)5.15%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%7.49%
Revenue Next Year5.25%
Revenue Next 2Y5.47%
Revenue Next 3Y5.89%
Revenue Next 5Y7.38%
EBIT growth 1Y21.82%
EBIT growth 3Y-9.05%
EBIT growth 5Y9.63%
EBIT Next Year57.21%
EBIT Next 3Y22.62%
EBIT Next 5Y14.77%
FCF growth 1Y31.74%
FCF growth 3Y5.12%
FCF growth 5Y55.1%
OCF growth 1Y29.99%
OCF growth 3Y1.77%
OCF growth 5Y15.28%